Search all ALPCO products, resources, and website information

Clinical Research
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.ALPCO has been serving the needs of clinical researchers and clinical diagnostics labs for over 30 years, and we now offer a broad product menu of proprietary automated sample-to-answer platforms. We’re ...
Platforms
Our platforms offer walk-away, sample-to-answer solutions for life science research, clinical research, and diagnosticsALPCO is a global leader in platforms for immunodiagnostics and molecular diagnostics. Our proprietary automated sample-to-answer solutions provide efficiency and ease-of-use for th...
Plate-Based ELISA
Leverage a Comprehensive Portfolio of ELISA KitsChoose from hundreds of ELISA kits to measure analytes in therapeutic areas including immunology, diabetes and obesity, infectious disease, gastroenterology, allergy, and more.Chemiluminescent and Colorimetric Plate-Based Assays  ALPCO offers hundred...
ALEX2 Allergy Xplorer Form
Request a Quote - ALEX Allergy Explorer
Simplify Stool Sample Processing
Introduction We understand the challenges facing lab managers and directors who need to continuously improve workflow efficiency and implement new tests and technologies to be competitive. Our unique extraction method can be used with a portfolio of targeted stool markers. This allows your lab to s...
Next-Gen Multiplex Allergy Testing with MADx
ALPCO has partnered with MacroArray Diagnostics, MADx, to offer a comprehensive testing solution for IgE-based allergies. MADx’s multiplex allergy test incorporates allergens covering 99% of globally relevant allergens, including pollen, pet allergens, dust mites, insect venom, foods, and mo...
MacroArray Diagnostics GmbH (MADx) partners with ALPCO to offer a fully automated sample-to-answer multiplex allergy test solution to the North American market
FOR IMMEDIATE RELEASE Salem, NH – February 1, 2022: ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together they offer a comprehensive line of testing ...
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50+ unique molec...
Food Intolerance Testing with MADx
ALPCO has partnered with MacroArray Diagnostics, MADx, to offer a comprehensive testing solution for IgG-based food intolerances. MADx’ multiplex food test offers a complete repertoire of relevant food antigens, including dairy, nuts, fruits/vegetables, spices and also superfoods such as alo...
Allergy Article Download
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives, vo...
ALPCO + GeneProof Merge to Form a Global Diagnostics Company
In April of this year, ALPCO proudly announced its merger with GeneProof. Together we are a global leader in immunodiagnostics and molecular diagnostics providing you, our customers, with reagents and proprietary automated sample-to-answer solutions for the tests that matter most to you. T...
Life Science and Clinical Diagnostics Solutions
Product Portfolio: Over 600 Kits to Measure Important Biomarkers. We are continuously expanding our portfolio of life sciences and clinical diagnostic solutions in support of the research community. ALPCO currently offers over 600 kits to measure important biomarkers in multiple species and sample t...
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives...
Complement System Solutions for Drug Development and Clinical Research
Datasheet: Complement System Immunoassays Download The complement system is essential to innate immunity which protects from chronic, autoimmune, and infectious disease. There are three distinct pathways of complement activation: classical, lectin/MBL, and alternative. Each leads...
Stool-Based Biomarkers to Differentiate Between IBD and IBS
What are IBD and IBS? Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues affecting millions of people every day. Although there is some overlap between symptoms of IBD and IBS, differences still remain in regards to pathologies, risks...
ALPCO Releases a New Broad Range Periostin ELISA
ALPCO is now offering a new broad range Periostin ELISA that has been optimized to detect all known splicing forms of human periostin. The Periostin ELISA is highly characterized with a full validation package, and offers great reproducibility and precision. Not only are all standards and controls i...
PI3K Delta Signaling in Rheumatoid Arthritis
Date: September 6, 2016 Author: Andrea Tarbet, Product Marketing Associate at ALPCO Signaling pathways dictate the differentiation, activation, and functions of immune cells.  Even the slightest problem in one cell signaling pathway can transform the immune system and turn it against the body,...
Introducing the STELLUX® Chemi Active GLP-1 (7-36) amide ELISA
Watch our video to learn more about the STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and how you can now measure this incretin hormone with confidence. https://www.youtube.com/watch?v=Chu3VhEEpt0&t=3s The STELLUX® Chemi Active GLP-1 (7-36) amide ELISA features increased sensitivity to ac...
ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo
July 25, 2018 ALPCO will exhibit at the AACC’s 70th Annual Clinical Lab Expo July 31-August 2, 2018 in Chicago, IL. The company will promote a number of tools to help research and improve clinical outcomes as well as increase laboratory efficiency. Among these tools are new and upcoming additi...
An Accurate Solution to the Challenges with Measuring GLP-1
Glucagon-like peptide-1 (GLP-1) is a gut hormone which plays an essential role in insulin secretion and glucose homeostasis1. While GLP-1 has become central to many metabolic disease research programs, various GLP-1 ELISA kits currently available on the market have been failing to meet the needs of ...
ALPCO’s Quality Management System Receives ISO 13485:2016 Certification
October 8, 2018 ALPCO recently announced that its quality management system received the distinguished ISO 13485:2016 certification from Intertek. ALPCO’s certification applies to the design, development, manufacture, and distribution of in vitro diagnostic reagents and kits. The Internati...
A Guide to STELLUX® Chemiluminscence ELISAs: An Infographic
Today, multiple immunoassay platforms exist, providing scientists and clinicians with the means to measure a variety of biomarkers1,2,3. However, research indicates some immunoassay platforms have limitations that can inhibit progress in the laboratory4,5,6. In an effort to provide researchers with ...
A Comparison of Colorimetric and Chemiluminescence ELISAs
Are you curious about chemiluminescence ELISAs, but not exactly sure what they are, or how to use them? Our video A Comparison of Colorimetric and Chemiluminescence ELISAs discusses how similar these two types of assays are, and how they can enhance your lab testing. Watch our video to: Lear...
ALPCO’s Calprotectin Validation Assistance Program
Whether your clinical laboratory is transitioning over to the ALPCO Calprotectin Chemiluminescence ELISA from another calprotectin assay or starting to run the test in-house for the first time, validation is the most crucial step in the assay implementation process. We understand that validating a n...